NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

MolMed S.p.A.

ClinicalTrials.gov Identifier:

NCT00675012

First received: May 5, 2008

Last updated: January 28, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2013
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)

Publications: